Situationmaterial
FDA clears C2N Diagnostics' PrecivityAD2 blood test for Alzheimer's diagnosis in adults aged 40+
Carried more widely than almost anything else in the last 30 days
◆ Sectors
Digital Health
◆ Where
United States
◆ Timeline
- 20 August 2026FDA clears C2N Diagnostics' PrecivityAD2 blood test for Alzheimer's diagnosis in adults aged 40+app.dealroom.co
- 21 August 2026FDA Clears PrecivityAD2 Blood Test for Alzheimer's in Adults as Young as 40clinicaltrialvanguard.com
- 22 August 2026FDA clears blood test to aid evaluation for Alzheimer's diseaseeurekalert.org
- 24 August 2026FDA-Cleared Alzheimer's Blood Test Marks a Shift Toward Earlier, Less Invasive Diagnosisinsideprecisionmedicine.com
- 4 September 2026New Blood Test for Alzheimer's Gets FDA Clearance—Here's How It Worksnewsweek.com
◆ Connected developments
Situations Wire finds semantically close to this one. Proximity, not cause.
◆ Share
◆ Wire has not analysed this situation yet
Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.
◆ Evidence
11 reports · 11 domains